Clients often have questions about how MIC Plus B12 works, what it supports and what to expect during treatment
They are made in the USA, free from allergens, and offer maximum absorption for fast, effective results
Bacteriostatic Water for Aegis Peptides
What subcutaneous (SubQ) injection means Subcutaneous = under the skin, into fat layer: Not into muscle (that's intramuscular) Not into vein (that's intravenous) Into fatty tissue between skin and muscle Slower absorption than IM, but adequate for BPC-157 Why SubQ for BPC-157: Easy to self-administer Less painful than IM Works well for systemic healing Can inject near injury sites Injection sites for SubQ Best locations: Abdomen (2 inches away from belly button) Thighs (front and outer sides) Upper arms (back of arm, need help or flexibility) Love handles/flanks Near injury: Can inject within 2-3 inches of injury Example: Shoulder injury = inject into shoulder area fat Knee injury = inject into thigh near knee Local injection may speed healing to that area Rotate sites: Don't inject same spot repeatedly Prevents tissue damage and scar tissue Rotate between abdomen, thighs, arms Different spot each injection SubQ injection step-by-step Step 1: Gather supplies Reconstituted BPC-157 (refrigerated) Insulin syringe (29-31 gauge, 1/2 inch needle) Alcohol wipes Sharps container for disposal Step 2: Prepare dose Remove BPC-157 from fridge Wipe vial top with alcohol Draw calculated dose (e.g., 25 units = 250mcg if using 2mg/ml concentration) Remove air bubbles Recap needle Step 3: Prepare injection site Choose injection area Clean with alcohol wipe Let dry (30 seconds) Step 4: Inject Pinch skin to create fold (makes it easier) Insert needle at 45-90 degree angle into pinched skin Insert fully (it's a short needle) Slowly inject (take 3-5 seconds) Remove needle quickly Step 5: After injection Apply gentle pressure with alcohol wipe if bleeding (rare) Don't massage injection site Return BPC-157 vial to refrigerator immediately Dispose of needle in sharps container Pain level: Minimal
This means the agency determined it cannot be used by licensed compounding pharmacies for compounded medications under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act
